[Archyde.com, Seoul, 12th]–The Korean Ministry of Food and Drug Safety announced on the 12th that it has approved the use of the new coronavirus vaccine developed by the US biopharmacy company Nuvaxovid. In addition, Pfizer’s new oral corona drug “Paxlobido” is expected to be distributed within the week. Prepare for the spread of a new variant of the new corona, Omicron.
According to the Ministry of Health, at least 21,000 doses of Pfizer will arrive in South Korea on the 13th. It is expected that another 10,000 doses will arrive by the end of the month.
After the 14th, it will be used for the treatment of more than 1000 people per day. The drug received an emergency use authorization in South Korea last December.
Meanwhile, the Korea Disease Control and Prevention Agency (KDCA) announced that the number of new corona infections per day was 4,388 as of midnight on the 11th. Compared to mid-December last year, when the number of people surged to nearly 8,000, the highest number ever, it is calming down.
According to health officials, the proportion of people infected with the Omicron strain was over 12.5%, up from 4% at the end of December.
.
